GlassScriptPhysician profile
Rachel L Dunn
NPI 1063941821
$347.21
in general payments reported to CMS, 2019-2025
13 companies · $99.26 in 2025
The $99.26 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.83 · 2022: $64.04 · 2023: $51.67 · 2024: $101 · 2025: $99.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $84.67 | 2023-2024 | |
| Hollister Incorporated | $48.96 | 2025 | New Image |
| Triad Life Sciences INC. | $31.45 | 2022 | |
| Mimedx Group, INC. | $29.44 | 2025 | |
| Bsn Medical INC | $20.86 | 2025 | |
| Acacia Pharma INC | $20.47 | 2022 | |
| Kci USA, INC. | $19.61 | 2023 | Promogran Prisma, Kerramax Care, Activ.A.C. |
| Amarin Pharma, INC. | $18.24 | 2021 | |
| Solventum Corporation | $17.51 | 2024 | V.A.C. Veraflo, V.A.C.Ulta |
| Urgo Medical North America, LLC | $16.81 | 2024 | Urgok2 |
| Pulmonx Corporation | $14.48 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $12.59 | 2021 | |
| Ani Pharmaceuticals, INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.